CIK 0001725430
- Non-accelerated filer
- Smaller reporting company
INTELLIGENT BIO SOLUTIONS INC.
Sign in to watch- Ticker
- INBS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 821512711
- Phone
- +1 646-790-5756
- Business address
- 135 W 41ST ST,, FLOOR 5, NEW YORK, NY, 10036
- Former names
- GBS Inc., Glucose Biosensor Systems (Greater China) Holdings, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-18 | Sakiris Spiro Kevin Chief Financial Officer | Grant or award | +9,150 | 12,631 | ||
| 2026-03-18 | Sakiris Spiro Kevin Chief Financial Officer | Grant or award | +21,350 | 33,981 | ||
| 2024-09-25 | Sakiris Spiro Kevin Chief Financial Officer | Grant or award | +34,500 | 34,815 | ||
| 2024-09-25 | Sakiris Spiro Kevin Chief Financial Officer | Grant or award | +34,500 | 34,815 | ||
| 2024-03-20 | Sakiris Spiro Kevin Chief Financial Officer | Option exercise | +9,394 | 19,180 | ||
| 2024-03-20 | Sakiris Spiro Kevin Chief Financial Officer | Option exercise · Common Stock Warrants (Series F) | −9,394 | 0 | ||
| 2023-10-04 | Sakiris Spiro Kevin Chief Financial Officer | Purchase | +112,727 | 117,427 | ||
| 2023-10-04 | Sakiris Spiro Kevin Chief Financial Officer | Purchase · Common Stock Warrants (Series E) | +112,727 | 112,727 | ||
| 2023-10-04 | Sakiris Spiro Kevin Chief Financial Officer | Purchase · Common Stock Warrants (Series F) | +112,727 | 112,727 | ||
| 2023-05-10 | Sakiris Spiro Kevin Chief Financial Officer | Conversion | +2,399 | $5.80 | $14K | 4,745 |
| 2023-05-10 | Sakiris Spiro Kevin Chief Financial Officer | Conversion · Series D Convertible Preferred Stock | −15,993 | 0 | ||
| 2022-12-22 | Sakiris Spiro Kevin Chief Financial Officer | Purchase · Series D Convertible Preferred Stock | +15,992 | $0.87 | $14K | 15,993 |
| 2022-12-22 | Sakiris Spiro Kevin Chief Financial Officer | Purchase · Common Stock Purchase Warrant | +47,979 | $0.13 | $6K | 47,979 |
| 2022-10-10 | Sakiris Spiro Kevin Chief Financial Officer | Grant or award | +75,000 | 125,228 | ||
| 2022-06-22 | Sakiris Spiro Kevin Chief Financial Officer | Purchase | +5,000 | $0.65 | $3K | 50,228 |
| 2022-06-17 | Sakiris Spiro Kevin ChiefFinancial Officer | Purchase | +15,970 | $0.61 | $10K | 45,228 |
| 2021-12-06 | Sakiris Spiro Kevin ChiefFinancial Officer | Purchase | +10,000 | $1.70 | $17K | 29,258 |
| 2021-05-19 | Sakiris Spiro Kevin Chief Financial Officer | Purchase | +10,000 | $3.07 | $31K | 16,258 |
| 2021-01-04 | Sakiris Spiro Kevin Chief Financial Officer | Option exercise | +1,479 | 6,258 | ||
| 2021-01-04 | Sakiris Spiro Kevin Chief Financial Officer | Option exercise · Series B Warrants | −1,479 | 0 |
Page 1 of 1 · 20 trades